Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Phreesia, Inc.

PHRNYSE
Wall Street Score · overall investment33/100
$12.37USD+$0.08 (+0.65%)
Company website www.phreesia.com
Headquarters1521 Concord Pike, Wilmington, DE, 19803, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Healthcare Information Services
Price from Oct 29, 2026Financials updated Oct 12, 2026

PHR · Price history

Price at last available close

$12.37

+$2.36 (+23.58%) 1M

2026-10-28

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Phreesia, Inc.

Primary reporting period: 2026-01-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks.

How they make money

Phreesia generates revenue primarily through subscription-based fees from healthcare services clients for its software platform and through transaction-based fees for payment processing services. Additionally, the company earns revenue from life sciences organizations that pay to deliver targeted educational content and health-related information to patients through the Phreesia platform.

Products & services

Phreesia provides an integrated software, payments, and engagement platform that supports the patient journey, including care discovery, scheduling, intake, payment processing, and post-visit follow-up via mobile devices, tablets, and kiosks.

Brands & revenue mix

Phreesia

The primary brand under which the company's integrated software, payments, and engagement platform is marketed.

Separate brand revenue is not available in this research.Source

Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.

Product / operating segments

Subscription And ServicesUSD 219.46M45.7%

Period ended 2026-01-31Source

Network SolutionsUSD 139.67M29.1%

Period ended 2026-01-31Source

Payment SolutionsUSD 121.46M25.3%

Period ended 2026-01-31Source

Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

  • Healthcare services organizationsSource
  • Life sciences organizationsSource

Customer concentration

The company does not have any single customer that accounts for more than 10% of its total revenue as of the fiscal year ended January 31, 2026.

Suppliers, materials & equipment

  • Cloud infrastructure and hosting providers — The company relies on third-party cloud infrastructure providers to host its platform and store data; specific supplier names are unnamed.Source

Strengths

  • Integrated platform addressing access, affordability, and outcomesSource
  • Significant market reach with approximately 180 million patient visits facilitated in fiscal 2026Source

Risks

  • Dependence on the healthcare industry and potential changes in healthcare regulationsSource
  • Risks associated with data privacy, security, and potential breaches of sensitive patient informationSource

Financial risk observations and what to check

These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-07-31.

Total debt increased 431.2% versus the same quarter last year.

Compare the added borrowing with available cash, cash generation and maturities. A percentage increase from a small starting balance can look large without measuring the full debt burden.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

33

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

49

Weak

Financial Strength

33

Business Quality / Moat

75

Management

52

Growth Quality

55

Risk / Durability

16

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

27

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

38/100

Building Historical Record

Model Score 38/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Asset quality scores strongly
What to watch
  • •Debt service risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Debt / balance-sheet profile needs attention

Company-specific research

Questions worth answering for PHR

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can PHR maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is PHR's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Does PHR's balance between cash and debt leave enough flexibility if business conditions weaken?
  • •What future growth or profitability would be needed to justify PHR's current valuation?
  • •What does the current fundamental change risk warning mean for the reliability or interpretation of PHR's score?
Debt service risk
Business analysis: 16 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

33

0–100 · Poor

Opportunity Score

27

0–100 · Poor

Market Cap

$767.8M

P/E Ratio

63.3

EPS

$0.17

52-Week High

$24.07

52-Week Low

$7.77

Beta

0.84

Intrinsic Value

$6.63

Analyst Target

$12.00

Shares Outstanding

61.5M

Total Revenue

$507.8M

Total Debt

$67.9M

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$6.05

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
81/ 100
-6 pts / 5d

Strong upward momentum

5D +0.9% · 20D +19.7% · RSI 77 · Price vs 20D avg +9.7%
Volatility
29/ 100
+2 pts / 5d

Low movement

20D realized vol 37.5% · 60D 44.5% · Acceleration 0.84x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for PHR

Detected from reported data — verify before acting.

Debt service risk

Interest coverage is low (~-1.0x). Earnings may be strained to cover interest expense.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on PHR.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Integrated platform addressing access, affordability, and outcomes.
  • +Significant market reach with approximately 180 million patient visits facilitated in fiscal 2026.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
  • −Dependence on the healthcare industry and potential changes in healthcare regulations.
  • −Risks associated with data privacy, security, and potential breaches of sensitive patient information.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak33/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

33

Tap for breakdown →

Poor

38

Debt Cost6.8%
Debt Reduction YoY-475.5%
Debt / Equity0.30x

Tap for breakdown →

Poor

29

Revenue YoY5.7%
Revenue CAGR16.1%
Net Margin2.1%

Tap for breakdown →

Strong

87

Asset Growth YoY70.9%
Liquidation/Share$6.05
Net Assets/MCap0.86x

Tap for breakdown →

Poor

14

Earnings Yield1.6%
Buyback Yield1.2%
Debt Cost6.8%

Tap for breakdown →

Fair

52

ROIC-1.8%
ROE2.8%
ROA1.6%

Tap for breakdown →

Strong

75

EPS Growth—
FCF/Share Growth664.8%
Rev/Share Growth3.1%

Tap for breakdown →

Poor

0

Intrinsic Value$6.63
Value Reference$3.98
MOS-81.8%

Tap for breakdown →

Weak

47

Revenue29
Moat75
Valuation0

Tap for breakdown →

Poor

0

MOS %-81.8%
Value Reference$3.98
Deep Discount Reference$2.65

Tap for breakdown →

Poor

28

Interest Coverage-1.0x
ROIC-1.8%
FCF Yield10.1%

Tap for breakdown →

Poor

24

Financial28
Valuation0
Debt38

Tap for breakdown →

Weak

40

Survival Years0.3 yrs
Current Ratio1.53x
FCF Margin14.1%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

3 historical score records available

Previous Score

34

Oct 1, 2026

Change

-0.3

points

Current Score

33

Oct 12, 2026

Category Changes

Revenue-0.6
Debt0
Assets-1.9
Capital-1.0
Management0
Moat0
Valuation0
Buffett-0.4

PHR decreased 0.3 points because some fundamentals weakened.

Projected Score

Projected Score

38

Projected Change

+4.8 points

Preliminary comparable-period financial changes suggest improvement of approximately 4.8 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$12.37

Model Intrinsic Value

$6.63

Difference

+$5.74

+86.6% vs IV

Margin of Safety

-86.6%

UndervaluedFair ValueOvervalued
Value Reference: $3.98
Deep Discount Reference: $2.65

Financial Charts

Revenue

201820192020202120222023202420252026$0$150M$300M$450M$600M

Additional Metrics

Operating Cash Flow

201820192020202120222023202420252026-$100M-$50M$0$50M$100M

Total Debt

201820192020202120222023202420252026$0$30M$60M$90M$120M

Total Assets

201820192020202120222023202420252026$0$200M$400M$600M$800M

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM202620252024202320222021202020192018
Revenue$507.8M$480.6M$419.8M$356.3M························
Cost of Revenue$185.1M$154.1M$134.9M$124.0M························
Gross Profit$322.7M$326.5M$284.9M$232.3M························
Research & Development$116.3M$121.5M$117.4M$112.3M························
SG&A Expenses$176.9M$180.1M$197.7M$226.9M························
Operating Expenses$306.5M$333.1M$343.0M$368.8M························
EBITDA$56.1M$29.5M-$25.6M-$104.0M························
Operating Income$16.2M-$6.6M-$58.1M-$136.5M························
Interest Expense$10.7M$7.0M$2.3M$1.9M························
Income Before Tax$2.8M-$8.9M-$55.8M-$135.3M························
Income Tax Expense-$7.7M-$11.2M$2.7M$1.5M························
Net Income$10.4M$2.3M-$58.5M-$136.9M························
Basic EPS$0.17$0.04$-1.02$-2.51························
Basic Shares61.88M59.74M57.59M54.56M························
Diluted Shares62.46M61.49M57.59M54.56M························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:Dec 14, 2026
Estimated EPS: $0.13Estimated revenue: $128.4M
Jul 31, 2026Q2FY2027

Revenue

$129.5M

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.03

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

+431.2%

Cash Change

-25.8%

Margin Change

+0.9 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded

What Weakened

  • Cash position declined
  • Debt increased

Potential Score Impact

Positive indicators included revenue growth, EPS growth, net income margin. Pressure indicators included cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 10.4%. EPS increased 189.6%. Cash declined 25.8%. Total debt increased 431.2%. Net income margin improved by 0.9 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 89 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

Smart Money

Number of Gurus

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Loading data...

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Dividend data is not available yet. Missing data does not mean this company pays no dividend.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

3 historical records
Jul 24, 26Oct 1, 26Oct 12, 260255075100

Historical Score Chart

3 of 3 records shown

Wall Street Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Debt Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Revenue Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Asset Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Capital Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Management Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Moat Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Valuation Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Buffett Score

Jul 24, 26Oct 1, 26Oct 12, 260255075100

Intrinsic Value

Jul 24, 26Oct 1, 26Oct 12, 26$0.00$2.00$4.00$6.00$8.00

Value Reference

Jul 24, 26Oct 1, 26Oct 12, 26$0.80$1.60$2.40$3.20$4.00

Margin of Safety %

Jul 24, 26Oct 1, 26Oct 12, 26-1.1%-0.9%-0.8%-0.6%-0.5%

Related Companies

Medical - Healthcare Information Services

DOCS

Doximity, Inc.

55Fair
$34.03View

HQY

HealthEquity, Inc.

48Weak
$101.50View

OPRX

OptimizeRx Corp.

43Weak
$9.08View

OMDA

Omada Health

42Weak
$19.34View

PRVA

Privia Health Group, Inc.

41Weak
$22.93View

CCLD

CareCloud, Inc.

41Weak
$1.82View

News

Rumor Mill · PHR

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial